These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 8222772)
1. Prevention of Pneumocystis carinii pneumonia relapse in AIDS patients. The efficacy and tolerability of low-dose sulfamethoxazole-trimethoprim. Nielsen TL; Jensen BN; Nelsing S; Pedersen C; Mathiesen LR; Skinhøj P; Nielsen JO Dan Med Bull; 1993 Sep; 40(4):503-5. PubMed ID: 8222772 [TBL] [Abstract][Full Text] [Related]
2. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group. Chaisson RE; Keruly J; Richman DD; Moore RD Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373 [TBL] [Abstract][Full Text] [Related]
3. A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients. Martin MA; Cox PH; Beck K; Styer CM; Beall GN Arch Intern Med; 1992 Mar; 152(3):523-8. PubMed ID: 1546914 [TBL] [Abstract][Full Text] [Related]
4. Treatment of Pneumocystis carinii pneumonia in patients with AIDS. Wordell CJ; Hauptman SP Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063 [TBL] [Abstract][Full Text] [Related]
5. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation. Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703 [TBL] [Abstract][Full Text] [Related]
6. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). El-Sadr WM; Luskin-Hawk R; Yurik TM; Walker J; Abrams D; John SL; Sherer R; Crane L; Labriola A; Caras S; Pulling C; Hafner R Clin Infect Dis; 1999 Oct; 29(4):775-83. PubMed ID: 10589887 [TBL] [Abstract][Full Text] [Related]
7. [Prevention of Pneumocystis carinii pneumonia with intermittent trimethoprim-sulfamethoxazole]. Luzzati R; Raviglione MC Minerva Med; 1992 Oct; 83(10):641-6. PubMed ID: 1461536 [TBL] [Abstract][Full Text] [Related]
8. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia. Warnock AC; Rimland D Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975 [TBL] [Abstract][Full Text] [Related]
9. Low-dose intermittent trimethoprim-sulfamethoxazole for prevention of Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. Wormser GP; Horowitz HW; Duncanson FP; Forseter G; Javaly K; Alampur SK; Gilroy SA; Lenox T; Rappaport A; Nadelman RB Arch Intern Med; 1991 Apr; 151(4):688-92. PubMed ID: 1901482 [TBL] [Abstract][Full Text] [Related]
10. [Sulfamethoxazole-trimethoprim-induced pneumonitis in a patient with hemophilia B who was infected with the human immunodeficiency virus]. Yamagishi T; Yoshida S; Fukutake K; Utsumi K; Ichinose Y Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jul; 34(7):822-8. PubMed ID: 8810766 [TBL] [Abstract][Full Text] [Related]
11. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. Hardy WD; Feinberg J; Finkelstein DM; Power ME; He W; Kaczka C; Frame PT; Holmes M; Waskin H; Fass RJ N Engl J Med; 1992 Dec; 327(26):1842-8. PubMed ID: 1448121 [TBL] [Abstract][Full Text] [Related]
12. Mild rhabdomyolysis after high-dose trimethoprim-sulfamethoxazole in a patient with HIV infection. Anders HJ; Bogner JR; Goebel FD Eur J Med Res; 1997 May; 2(5):198-200. PubMed ID: 9153343 [TBL] [Abstract][Full Text] [Related]
13. Hyperkalemia associated with high-dose trimethoprim-sulfamethoxazole in a patient with the acquired immunodeficiency syndrome. Mihm LB; Rathbun RC; Resman-Targoff BH Pharmacotherapy; 1995; 15(6):793-7. PubMed ID: 8602391 [TBL] [Abstract][Full Text] [Related]
14. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. Hughes W; Leoung G; Kramer F; Bozzette SA; Safrin S; Frame P; Clumeck N; Masur H; Lancaster D; Chan C N Engl J Med; 1993 May; 328(21):1521-7. PubMed ID: 8479489 [TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study. Hoover DR; Saah AJ; Bacellar H; Phair J; Detels R; Anderson R; Kaslow RA N Engl J Med; 1993 Dec; 329(26):1922-6. PubMed ID: 7902536 [TBL] [Abstract][Full Text] [Related]